openPR Logo
Press release

Cardiac Resynchronization Therapy Systems Market to Grow at a CAGR of 5.3% through 2025

08-06-2018 09:34 AM CET | Health & Medicine

Press release from: Transparency Market Research

transparency market research

transparency market research

The global Cardiac Resynchronization Therapy Systems market was valued at approximately US$ 3.1 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 5.3% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cardiac Resynchronization Therapy Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that surge in incidences of heart failure is spur the demand of cardiac resynchronization therapy systems in the coming years (2017 to 2025). . Increased rate of Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator implantations in heart failure patients is propelling the Cardiac Resynchronization Therapy Systems Market growth in North America and Western Europe, these regions are likely to account for dominating share of the global cardiac resynchronization therapy systems market. Changing dietary habits and sedentary lifestyle trends in emerging markets such as China and India is likely to boost growth of Asia Pacific cardiac resynchronization therapy systems market during the forecast period of 2017 to 2025.

Request For Sample copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40463

Rising Prevalence of Heart Failure is expected to Drive Global Market

Prevalence of heart failure is expected to increase exponentially worldwide due to change in lifestyle and various factors such as malnutrition, genetic mutations, and others. According to various government and private organizations operating in the cardiovascular industry, heart failure is considered one of the top reasons of mortality worldwide. Globally 26 million people are affected by heart failure. Cardiac resynchronization therapy (CRT) systems are used to treat conditions such as heart failure. The cardiac resynchronization therapy system device works by resynchronizing the contractions of heart ventricles by sending the electrical signals to the heart muscle. The device is implanted as a combination of CRT device and a pacemaker, and a CRT and pacemaker and defibrillator helping in better heart pumping and improved blood flow.

The CRT device is usually implanted just below the skin in the chest area

Cardiac Resynchronization Therapy Defibrillator to Contribute Maximum Market Share

The global Cardiac Resynchronization Therapy Systems Market has been segmented based on product type, and geography. Considering the product type the global Cardiac Resynchronization Therapy Systems Market is classified in to major segments- Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator. Cardiac resynchronization therapy pacemaker (CRT-P) also known as bi ventricular pacing is an implantable cardiac resynchronization therapy (CRT) pacemaker for patients with heart failure. The device monitors the heart’s rhythm, detects irregularities and corrects them with electrical impulses. Cardiac resynchronization therapy defibrillator (CRT-D) is implanted in heart failure patients who are at a high risk of sudden cardiac arrest.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40463

The cardiac resynchronization therapy defibrillator (CRT-D) contributed a share of 92.1% in terms of revenue of the global Cardiac Resynchronization Therapy Systems Market in the year 2016. According to the research presented at the American College of Cardiology’s 63rd Annual Scientific Session, patients suffering from mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with a traditional implantable cardioverter defibrillator (ICD). Thus this segment is the major segment contributing the maximum share in terms of revenue to the Global Cardiac Resynchronization Therapy Systems Market.

China is a rapidly expanding market for cardiac resynchronization therapy systems in Asia Pacific.

Geographically, the global Cardiac Resynchronization Therapy Systems Market can be segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Based on geographic distribution, North America dominated the global Cardiac Resynchronization Therapy Systems Market followed by Europe in 2016. Advancement in technology and awareness of cardiovascular and associated diseases are the key reasons for growth of Cardiac Resynchronization Therapy Systems Market in these regions. The region accounted for prominent share of the global Cardiac Resynchronization Therapy Systems Market in the same year. China is a rapidly expanding market for cardiac resynchronization therapy systems in Asia Pacific.

Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40463

The country is anticipated to account for maximum share of the market in the region by 2025. According to a study published in Circulation Journal Vol.77, there are 4.2 million people with heart failure in China having a prevalence rate of 1.3% and 500,000 new cases of heart failure are diagnosed every year. The market in the Middle East is in the developing phase, which offers strong expansion potential in the near future due to increasing demand for CRT device implantations. Globally the Cardiac Resynchronization Therapy Defibrillator segment of the Cardiac Resynchronization Therapy Systems Market is expected to dominate the market during the forecast period.

Key Players such as Medtronic, Boston Scientific Corporation, Abbott are Likely to Continue to Lead the Global Cardiac Resynchronization Therapy Systems Market

The report also provide profiles of leading players operating in the global Cardiac Resynchronization Therapy Systems Market which include Medtronic, Boston Scientific Corporation, Abbott, LivaNova PLC, BIOTRONIK SE & Co. KG and others. Most companies are focusing on new product launch for expanding their business in cardiac resynchronization therapy systems. For instance, LivaNova PLC has announced the launch of next-generation range of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds). These are the major players of Cardiac Resynchronization Therapy Systems Market and exhibit the largest geographical outreach with presence of range of worldwide.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Resynchronization Therapy Systems Market to Grow at a CAGR of 5.3% through 2025 here

News-ID: 1163102 • Views: 141

More Releases from Transparency Market Research

Pre-Printed Paper Rolls Market Demand Analysis and Projected huge Growth by 2027
Pre-printed paper rolls can be a powerful marketing tool for any business. In addition to these pre-printed paper rolls can be used for several applications such as labels, tapes, QR codes, etc. Pre-printed paper rolls are cost-effective and form a brand impression on consumers. Pre-printed paper rolls can be printed in many colors. They are colorful and appealing and are not like ordinary papers. For More Detailed Analysis, Request PDF
Duffle Top Bulk Bags Market Generates Huge Revenue Till 2027- Study By Key Playe …
Duffle top bulk bags made from plastic last long and are highly durable. Duffle top bulk bags are flexible and are strong to carry heavy loads. They have lift straps fixed at the top of the bag, which helps in handling and movement of duffle top bulk bags. Duffle top bulk bags can be of various types, which include opening from the bottom or opening from top. They are lightweight
Multi-Dose Packaging System Market Demand & Future Scope Including Top Players
Medicinal wastage and error in taking proper medication lead to need for multi-dose packaging system. Multi-dose packaging system has various benefits, which includes assisting patients with complicated prescription routines and the ability to enhance patient safety. It provides high-quality, smart packaging and also provides convenience to the patients. Multi-dose packaging system provides consumers with product protection, quality, and patient comfort. It has normal handling, and the formulation present in the
Cargo Belt Market 2020 Growth Rate, Developments in Major Areas, Market Size, Dy …
Globalization leads to the need for transportation of goods over the longer distance. This will drive the demand for cargo belts in the logistics & transportation industry. During the transportation of goods, about one-fourth of the accidents occurred due to poor handling of goods, which can be avoided by using the cargo belt. They are used in light and heavy lorries, trailers trucks, ships, and air crafts. Request PDF Sample For

All 5 Releases


More Releases for Cardiac

Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are